Aion Therapeutic Inc. (CSE:AION) announced that it plans to complete a second tranche of its non-brokered private placement of units.
The company told investors it will raise additional gross proceeds of up to $300,000 through the issuance of up to an additional 30,000,000 units for $0.01 each. The units will consist of one common share and one-half of one common share purchase warrant, with each full warrant exercisable to acquire an additional share for 18 months at $0.10 per share.
It said it intends to use the proceeds of the offering for general working capital purposes.